Jasminka Sterjovski

发表

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS

M. Churchill, D. Purcell, S. Wesselingh, 2007, Retrovirology.

Site-Selective Solid-Phase Synthesis of a CCR5 Sulfopeptide Library To Interrogate HIV Binding and Entry

R. Payne, M. Stone, P. Gorry, 2014, ACS chemical biology.

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression

M. Churchill, D. Purcell, J. Albert, 2008, Retrovirology.

Genetic and Functional Analysis of R5X4 Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Derived from Two Individuals Homozygous for the CCR5Δ32 Allele

M. Churchill, D. Purcell, S. Wesselingh, 2006, Journal of Virology.

Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.

M. Churchill, D. Purcell, N. Saksena, 2010, Virology.

Tissue-Specific Sequence Alterations in the Human Immunodeficiency Virus Type 1 Envelope Favoring CCR5 Usage Contribute to Persistence of Dual-Tropic Virus in the Brain

M. Churchill, D. Purcell, S. Wesselingh, 2009, Journal of Virology.

HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism

M. Churchill, S. Lewin, P. Gorry, 2011, Journal of Virology.

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations

Brendan L Wilkinson, M. Churchill, S. Lewin, 2013, Retrovirology.

Alternative Coreceptor Requirements for Efficient CCR5- and CXCR4-Mediated HIV-1 Entry into Macrophages

Paul A. Ramsland, M. Churchill, P. Gorry, 2011, Journal of Virology.

Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.

P. Gorry, P. Ramsland, J. Paull, 2011, Antiviral research.

Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity

S. Wesselingh, Mark Zanin, P. Gorry, 2010, PloS one.

CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity.

M. Churchill, S. Wesselingh, P. Gorry, 2011, Virology.

Macrophage‐tropic HIV‐1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5

M. Churchill, P. Gorry, N. Webb, 2013, Journal of leukocyte biology.

An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.

M. Churchill, S. Wesselingh, P. Gorry, 2010, Virology.

Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.

Steven L Wesselingh, Anthony L Cunningham, Lachlan Gray, 2005, Virology.

The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression.

M. Churchill, S. Wesselingh, P. Gorry, 2004, Sexual health.

Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies

T. Chou, P. Gorry, N. Webb, 2014, Retrovirology.

Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12.

M. Churchill, S. Wesselingh, P. Gorry, 2012, Virology.

Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source

M. Churchill, S. Wesselingh, D. McPhee, 2007, Virology Journal.

Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia.

M. Churchill, S. Wesselingh, B. Brew, 2004, The Journal of infectious diseases.

Astrocyte specific viral strains in HIV dementia

M. Churchill, S. Wesselingh, P. Gorry, 2004, Annals of neurology.

Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.

M. Churchill, D. Purcell, J. Albert, 2008, Virology.

HealthMap: a cluster randomised trial of interactive health plans and self-management support to prevent coronary heart disease in people with HIV

R. Osborne, A. Tonkin, S. Lewin, 2016, BMC Infectious Diseases.

Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge

M. Churchill, J. Albert, E. Fenyö, 2011, PloS one.

Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues

M. Churchill, P. Gorry, P. Ramsland, 2011, Retrovirology.

Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists.

M. Churchill, S. Lewin, J. Flynn, 2017, AIDS research and human retroviruses.

Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes

P. Harrigan, M. Churchill, P. Gorry, 2015, Scientific Reports.

Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection

H. Ullum, M. Churchill, D. Purcell, 2013, PloS one.

Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele.

M. Churchill, D. Purcell, S. Wesselingh, 2006, Journal of virology.

Covariance of Charged Amino Acids at Positions 322 and 440 of HIV-1 Env Contributes to Coreceptor Specificity of Subtype B Viruses, and Can Be Used to Improve the Performance of V3 Sequence-Based Coreceptor Usage Prediction Algorithms

M. Churchill, P. Gorry, P. Ramsland, 2014, PloS one.

CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm

M. Churchill, P. Gorry, M. Jakobsen, 2013, Retrovirology.

Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues

M. Churchill, P. Gorry, P. Ramsland, 2011, Retrovirology.

Tissue-Specific Sequence Alterations in the Human Immunodeficiency Virus Type 1 Envelope Favoring CCR5 Usage Contribute to Persistence of Dual-Tropic Virus in the Brain

M. Churchill, D. Purcell, S. Wesselingh, 2009, Journal of Virology.

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS

M. Churchill, P. Gorry, L. Gray, 2007, Retrovirology.

Asn 362 in Gp120 Contributes to Enhanced Fusogenicity by Ccr5- Restricted Hiv-1 Envelope Glycoprotein Variants from Patients with Aids Asn 362 in Gp120 Contributes to Enhanced Fusogenicity by Ccr5-restricted Hiv-1 Envelope Glycoprotein Variants from Patients with Aids

M. Churchill, P. Gorry, L. Gray, 2022 .

Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.

M. Churchill, D. Purcell, J. Albert, 2008, Virology.

009.3 Relibale genotypic tropism tests for the major hiv-1 subtypes

M. Churchill, L. Gray, P. Gorry, 2015 .

CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm

M. Churchill, P. Gorry, M. Jakobsen, 2013, Retrovirology.